Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025)

Alvotech's (ALVO) quarterly Net Equity Issued and Repurchased came in at -$55.6 million in Q2 2025, down 548.06% on a YoY basis from $12.4 million in Q2 2024, and down 140.25% quarter-over-quarter from $138.0 million in Q1 2025.

Analysis

Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

Alvotech (ALVO) has reported Net Equity Issued and Repurchased for 3 consecutive years, with -$55.6 million the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Net Equity Issued and Repurchased fell 548.06% year-over-year to -$55.6 million; the trailing twelve-month figure through Dec 2025 stood at $82.5 million (down 45.18% YoY), and the FY2025 full-year result was $82.5 million, down 45.18% from the prior year.
  • Net Equity Issued and Repurchased slipped to -$55.6 million in Q2 2025 per ALVO's latest filing, from $138.0 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $138.0 million in Q1 2024 and bottomed at -$55.6 million in Q2 2025.
  • Historically, Net Equity Issued and Repurchased has averaged $38.8 million across 3 years, with a median of $6.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased soared 620200.0% in 2024, then slumped 548.06% in 2025.
  • Over 3 years, Net Equity Issued and Repurchased stood at $2000.0 in 2023, then surged by 620000.0% to $12.4 million in 2024, then plunged by 548.06% to -$55.6 million in 2025.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$55.6 million, $138.0 million, and $12.4 million for Q2 2025, Q1 2025, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 700,000.00
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -55.57 Mn
Mar 31, 2025 138.05 Mn
Jun 30, 2024 12.40 Mn
Mar 31, 2024 138.05 Mn
Dec 31, 2023 2,000.00
Jun 30, 2023 -2,000.00